Internalization and subcellular trafficking of Poly- l -lysine dendrimers are impacted by the site of fluorophore conjugation

Molecular Pharmaceutics

Volumn 12, Issue 6, 2015, Pages 1961-1969

  Avaritt, Brittany R ^a   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

dendrimers; drug delivery; endocytosis; nanomedicine; trafficking

Indexed keywords

BIOLOGICAL MARKER; CAVEOLIN; CHOLESTEROL; CLATHRIN; DENDRIMER; DYE; DYNAMIN; OREGON GREEN 514; POLYLYSINE; UNCLASSIFIED DRUG; LYSINE;

ARTICLE; CACO 2 CELL LINE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; LYSOSOME; PINOCYTOSIS; PRIORITY JOURNAL; CHEMISTRY; METABOLISM; NANOMEDICINE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; DENDRIMERS; ENDOCYTOSIS; HUMANS; LYSINE; NANOMEDICINE;

EID: 84930661064     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500765e     Document Type: Article

References (49)

1. Esfand, R.; Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications Drug Discovery Today 2001, 6 (8) 427-436
2. Tomalia, D. A.; Reyna, L. A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem. Soc. Trans. 2007, 35 (Part 1) 61-67
3. Lee, C. C.; MacKay, J. A.; Frechet, J. M.; Szoka, F. C. Designing dendrimers for biological applications Nat. Biotechnol. 2005, 23 (12) 1517-1526
4. Gupta, U.; Agashe, H. B.; Asthana, A.; Jain, N. K. Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement Biomacromolecules 2006, 7 (3) 649-658
5. Kaminskas, L. M.; McLeod, V. M.; Kelly, B. D.; Cullinane, C.; Sberna, G.; Williamson, M.; Boyd, B. J.; Owen, D. J.; Porter, C. J. Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models Mol. Pharmaceutics 2012, 9 (3) 422-432
6. Fox, M. E.; Guillaudeu, S.; Frechet, J. M.; Jerger, K.; Macaraeg, N.; Szoka, F. C. Synthesis and in vivo antitumor efficacy of PEGylated poly(l -lysine) dendrimer-camptothecin conjugates Mol. Pharmaceutics 2009, 6 (5) 1562-1572
7. Kaminskas, L. M.; Kelly, B. D.; McLeod, V. M.; Boyd, B. J.; Krippner, G. Y.; Williams, E. D.; Porter, C. J. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly- l -lysine dendrimers Mol. Pharmaceutics 2009, 6 (4) 1190-1204
8. Kaminskas, L. M.; Kelly, B. D.; McLeod, V. M.; Sberna, G.; Owen, D. J.; Boyd, B. J.; Porter, C. J. Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker J. Controlled Release 2011, 152 (2) 241-248
9. Gurdag, S.; Khandare, J.; Stapels, S.; Matherly, L. H.; Kannan, R. M. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines Bioconjugate Chem. 2006, 17 (2) 275-283
10. Teow, H. M.; Zhou, Z.; Najlah, M.; Yusof, S. R.; Abbott, N. J.; D"Emanuele, A. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier Int. J. Pharm. 2013, 441 (1-2) 701-711
11. Goldberg, D. S.; Vijayalakshmi, N.; Swaan, P. W.; Ghandehari, H. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity J. Controlled Release 2011, 150 (3) 318-325
12. Kolhatkar, R. B.; Swaan, P.; Ghandehari, H. Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers Pharm. Res. 2008, 25 (7) 1723-1729
13. Sadekar, S.; Thiagarajan, G.; Bartlett, K.; Hubbard, D.; Ray, A.; McGill, L. D.; Ghandehari, H. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin Int. J. Pharm. 2013, 456 (1) 175-185
14. Kitchens, K. M.; Kolhatkar, R. B.; Swaan, P. W.; Ghandehari, H. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells Mol. Pharmaceutics 2008, 5 (2) 364-369
15. Goldberg, D. S.; Ghandehari, H.; Swaan, P. W. Cellular entry of G3.5 poly(amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia Pharm. Res. 2010, 27 (8) 1547-1557
16. Seib, F. P.; Jones, A. T.; Duncan, R. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells J. Controlled Release 2007, 117 (3) 291-300
17. Kitchens, K. M.; Foraker, A. B.; Kolhatkar, R. B.; Swaan, P. W.; Ghandehari, H. Endocytosis and interaction of poly(amidoamine) dendrimers with Caco-2 cells Pharm. Res. 2007, 24 (11) 2138-2145
18. Boyd, B. J.; Kaminskas, L. M.; Karellas, P.; Krippner, G.; Lessene, R.; Porter, C. J. Cationic poly- l -lysine dendrimers: Pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats Mol. Pharmaceutics 2006, 3 (5) 614-627
19. Kaminskas, L. M.; Boyd, B. J.; Karellas, P.; Krippner, G. Y.; Lessene, R.; Kelly, B.; Porter, C. J. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l -lysine dendrimers Mol. Pharmaceutics 2008, 5 (3) 449-463
20. Kaminskas, L. M.; Wu, Z.; Barlow, N.; Krippner, G. Y.; Boyd, B. J.; Porter, C. J. Partly-PEGylated poly- l -lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers J. Pharm. Sci. 2009, 98 (10) 3871-3875
21. Nandi, P. K.; Van Jaarsveld, P. P.; Lippoldt, R. E.; Edelhoch, H. Effect of basic compounds on the polymerization of clathrin Biochemistry 1981, 20 (23) 6706-6710
22. Phonphok, Y.; Rosenthal, K. S. Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines FEBS Lett. 1991, 281 (1-2) 188-190
23. Heuser, J. Effects of cytoplasmic acidification on clathrin lattice morphology J. Cell Biol. 1989, 108 (2) 401-411
24. Gibson, A. E.; Noel, R. J.; Herlihy, J. T.; Ward, W. F. Phenylarsine oxide inhibition of endocytosis: Effects on asialofetuin internalization Am. J. Physiol. 1989, 257 (2, Part 1) C182-C184
25. Griendling, K. K.; Delafontaine, P.; Rittenhouse, S. E.; Gimbrone, M. A., Jr.; Alexander, R. W. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells J. Biol. Chem. 1987, 262 (30) 14555-14562
26. Zimmerberg, J.; Kozlov, M. M. How proteins produce cellular membrane curvature Nat. Rev. Mol. Cell Biol. 2006, 7 (1) 9-19
27. McGookey, D. J.; Fagerberg, K.; Anderson, R. G. Filipin-cholesterol complexes form in uncoated vesicle membrane derived from coated vesicles during receptor-mediated endocytosis of low density lipoprotein J. Cell Biol. 1983, 96 (5) 1273-1278
28. Simionescu, N.; Lupu, F.; Simionescu, M. Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium J. Cell Biol. 1983, 97 (5, Part 1) 1592-1600
29. Parton, R. G.; Joggerst, B.; Simons, K. Regulated internalization of caveolae J. Cell Biol. 1994, 127 (5) 1199-1215
30. Pelkmans, L.; Puntener, D.; Helenius, A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae Science 2002, 296 (5567) 535-539
31. Klein, U.; Gimpl, G.; Fahrenholz, F. Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor Biochemistry 1995, 34 (42) 13784-13793
32. Ohtani, Y.; Irie, T.; Uekama, K.; Fukunaga, K.; Pitha, J. Differential effects of α-, β- and Γ-cyclodextrins on human erythrocytes Eur. J. Biochem. 1989, 186 (1-2) 17-22
33. Hailstones, D.; Sleer, L. S.; Parton, R. G.; Stanley, K. K. Regulation of caveolin and caveolae by cholesterol in MDCK cells J. Lipid Res. 1998, 39 (2) 369-379
34. Rodal, S. K.; Skretting, G.; Garred, O.; Vilhardt, F.; van Deurs, B.; Sandvig, K. Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles Mol. Biol. Cell 1999, 10 (4) 961-974
35. Macia, E.; Ehrlich, M.; Massol, R.; Boucrot, E.; Brunner, C.; Kirchhausen, T. Dynasore, a cell-permeable inhibitor of dynamin Dev. Cell 2006, 10 (6) 839-850
36. Cao, H.; Chen, J.; Awoniyi, M.; Henley, J. R.; McNiven, M. A. Dynamin 2 mediates fluid-phase micropinocytosis in epithelial cells J. Cell Sci. 2007, 120 (Part 23) 4167-4177
37. Kirchhausen, T.; Macia, E.; Pelish, H. E. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis Methods Enzymol. 2008, 438, 77-93
38. Lim, J. P.; Gleeson, P. A. Macropinocytosis: An endocytic pathway for internalising large gulps Immunol. Cell Biol. 2011, 89 (8) 836-843
39. Araki, N.; Johnson, M. T.; Swanson, J. A. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages J. Cell Biol. 1996, 135 (5) 1249-1260
40. Hansen, S. H.; Olsson, A.; Casanova, J. E. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells J. Biol. Chem. 1995, 270 (47) 28425-28432
41. Rojas, R.; Apodaca, G. Immunoglobulin transport across polarized epithelial cells Nat. Rev. Mol. Cell Biol. 2002, 3 (12) 944-955
42. Wilson, J. M.; de Hoop, M.; Zorzi, N.; Toh, B. H.; Dotti, C. G.; Parton, R. G. EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts Mol. Biol. Cell 2000, 11 (8) 2657-2671
43. Thompson, A.; Nessler, R.; Wisco, D.; Anderson, E.; Winckler, B.; Sheff, D. Recycling endosomes of polarized epithelial cells actively sort apical and basolateral cargos into separate subdomains Mol. Biol. Cell 2007, 18 (7) 2687-2697
44. Dufes, C.; Uchegbu, I. F.; Schatzlein, A. G. Dendrimers in gene delivery Adv. Drug Delivery Rev. 2005, 57 (15) 2177-2202
45. Duncan, R.; Richardson, S. C. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: Opportunities and challenges Mol. Pharmaceutics 2012, 9 (9) 2380-2402
46. Kitchens, K. M.; Kolhatkar, R. B.; Swaan, P. W.; Eddington, N. D.; Ghandehari, H. Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling Pharm. Res. 2006, 23 (12) 2818-2826
47. Tiriveedhi, V.; Kitchens, K. M.; Nevels, K. J.; Ghandehari, H.; Butko, P. Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes Biochim. Biophys. Acta 2011, 1808 (1) 209-218
48. Fuller, S. D.; Simons, K. Transferrin receptor polarity and recycling accuracy in "tight and "leaky strains of Madin-Darby canine kidney cells J. Cell Biol. 1986, 103 (5) 1767-1779
49. Kurtoglu, Y. E.; Mishra, M. K.; Kannan, S.; Kannan, R. M. Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers Int. J. Pharm. 2010, 384 (1-2) 189-194